sellWeak cluster of 410b5-1 plan
Deborah Ann Miller sold $593k of NUVL
Chief Legal Officer at Nuvalent, Inc.. 5,500 shares at an average of $107.84, traded May 28, 2026, filed Jun 1, 2026.
Warning score
14Value
$593k
5,500 shares
Holdings after
59,634
-8% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +19Trade size$593k at market
- 0Share of holdings soldSold 8.4% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001868741-26-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 28, 2026 | MOption exercise Class A Common Stock10b5-1 | +5,500 | $6.89 | $38k | 65,134 | Jun 1, 2026 |
| May 28, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -1,401 | $106.32 | $149k | 63,733 | Jun 1, 2026 |
| May 28, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -1,530 | $107.45 | $164k | 62,203 | Jun 1, 2026 |
| May 28, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -900 | $108.14 | $97k | 61,303 | Jun 1, 2026 |
| May 28, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -1,669 | $109.30 | $182k | 59,634 | Jun 1, 2026 |
| May 28, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,500 | $0.00 | $0 | 72,608 | Jun 1, 2026 |
Related signals
Other insiders at Nuvalent, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | Nuvalent, Inc. | Henry E. Pelish Chief Scientific Officer | $261k 2,111 shares | -3% | |
| 30Weak | Nuvalent, Inc. | James Richard Porter President and CEO | $3.7M 30,000 shares | -8% | |
| 32Weak | Nuvalent, Inc. | Alexandra Balcom Chief Financial Officer | $1.4M 11,430 shares | -12% | |
| 30Weak | Nuvalent, Inc. | Darlene Noci Chief Development Officer | $2.8M 23,000 shares | -28% | |
| 16Weak | Nuvalent, Inc. | Darlene Noci Chief Development Officer | $679k 5,500 shares | -9% | |
| 30Weak | Nuvalent, Inc. | Darlene Noci Chief Development Officer | $2.5M 20,000 shares | -26% | |
| 30Weak | Nuvalent, Inc. | James Richard Porter President and CEO | $2.7M 30,000 shares | -8% | |
| 32Weak | Nuvalent, Inc. | Alexandra Balcom Chief Financial Officer | $1.1M 11,430 shares | -12% | |
| 14Weak | Nuvalent, Inc. | Darlene Noci Chief Development Officer | $593k 5,500 shares | -9% | |
| 30Weak | Nuvalent, Inc. | James Richard Porter President and CEO | $3.1M 30,000 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.